$DMII SEC Filings

Filed On	Filing
14 Aug 2026	QUARTERLY REPORT
14 May 2026	QUARTERLY REPORT
28 Apr 2026	8-K: Entry into a Material Definitive Agreement
15 Apr 2026	ANNUAL REPORT
03 Apr 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
01 Apr 2026	NOTIFICATION OF LATE FILING
17 Mar 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
06 Mar 2026	8-K: Other Events
06 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
18 Nov 2025	QUARTERLY REPORT
18 Nov 2025	8-K: Departure/Election of Directors or Officers; Compensation
17 Nov 2025	NOTIFICATION OF LATE FILING
17 Oct 2025	Form 4: Do Catherine, Director Acquired 100,000 shares (Other Transaction)
02 Oct 2025	8-K: Other Events
02 Oct 2025	Form 4: Shulgan Myron W., Director Acquired 100,000 shares (Other Transaction)
02 Oct 2025	SCHEDULE 13D
01 Oct 2025	Form 4: Worman Glenn C., CFO Acquired 100,000 shares (Other Transaction)
01 Oct 2025	Form 4: Stockwell Lynn, Director Bought 700,000 shares · Disposed of 400,000 shares (Other Transaction) · Sold 7,966,667 shares · 1 more
01 Oct 2025	Form 4: Drugs Made In America Acquisition Ii Llc, 10% owner Bought 700,000 shares · Disposed of 400,000 shares (Other Transaction) · Sold 7,966,667 shares · 1 more
01 Oct 2025	Form 4: Prasad Sridhar G., Director Acquired 100,000 shares (Other Transaction)

Comments